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Abstract: Wild-type and variant crystals of a recombinant enzyme β-D-glucan 
glucohydrolase from barley (Hordeum vulgare L.) were obtained by macroseeding and 
cross-seeding with microcrystals obtained from native plant protein. Crystals grew to 
dimensions of up to 500  250  375 µm at 277 K in the hanging-drops by vapour-
diffusion. Further, the conditions are described that yielded the wild-type crystals with 
dimensions of 80  40  60 µm by self-nucleation vapour-diffusion in sitting-drops at  
281 K. The wild-type and recombinant crystals prepared by seeding techniques achived 
full size within 5-14 days, while the wild-type crystals grown by self-nucleation appeared 
after 30 days and reached their maximum size after another two months. Both the  
wild-type and recombinant variant crystals, the latter altered in the key catalytic and 
substrate-binding residues Glu220, Trp434 and Arg158/Glu161 belonged to the P43212 
tetragonal space group, i.e., the space group of the native microcrystals was retained in the 
newly grown recombinant crystals. The crystals diffracted beyond 1.57-1.95 Å and the cell 
dimensions were between a = b = 99.2-100.8 Å and c = 183.2-183.6 Å. With one molecule 
in the asymmetric unit, the calculated Matthews coefficients were between 3.4-3.5 Å3.Da-1 
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and the solvent contents varied between 63.4% and 64.5%. The macroseeding and cross-
seeding techniques are advantageous, where a limited amount of variant proteins precludes 
screening of crystallisation conditions, or where variant proteins could not be crystallized.  
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1. Introduction 
Plant β-D-glucan glucohydrolase enzymes are classified in the GH3 family of glycoside hydrolases 
(http://www.cazy.org/) that currently includes nearly 3,000 entries [1]. The majority of these entries 
represent nucleotide sequences obtained from sequencing of bacterial genomes. Almost all GH3 
entries have two, three or more individually folded domains, while the spatial arrangement of the 
domains varies [2,3]. A large proportion of the GH3 entries are enzymes that are variously annotated 
as β-D-glucosidases, glucan-1,4-β-D-glucosidases, (1,3)-β-D-glucan exohydrolases, (1,3;1,4)-β-D-
glucan exohydrolases, exo-1,3-1,4-β-D-glucanases, N-acetyl-β-D-glucosaminidases, xylan-1,4-β-D-
xylosidases and α-L-arabinofuranosidases [1]. Although the GH3 family contains predominantly 
enzymes, their substrate specificities have not been satisfactorily defined and the most of annotations 
are based on sequence similarities with enzymes for which biochemical data are available [4].  
We have focused our attention in the past upon the biochemical and structural characterization of  
β-D-glucan glucohydrolases from higher plants, in particular on barley β-D-glucan glucohydrolase, 
isoenzyme ExoI (designated as HvExoI). This enzyme was crystallized from a native plant source 
obtained from barley seedlings [5], although the procedure for isolation of a crystallisable quality of 
HvExoI is both time consuming and technically challenging [6]. Over the past ten years several 
structures (Protein Data Bank references 1EX1, 1IEQ, 1IEV, 1IEW, 1IEX, 1J8V, 1LQ2, 1X38, 1X39) 
have been solved from the native HvExoI crystals with substrate analogues and mechanism-based 
inhibitors to explain the enzyme’s catalytic mechanism and substrate specificity [2,7-10]. However, a 
few facets of catalytic and substrate binding mechanisms remain to be explained. To this end we are 
interested in the specific roles of amino acid residues in the vicinity of the catalytic pair and how 
specific structural determinants at the entrance of the catalytic pocket control spatial dispositions of 
isomeric oligosaccharides entering the catalytic site. Further, we have been intrigued by so-called 
substrate-product trafficking events at the mouth of the catalytic site [2,7]. Here, the glucose product of 
the hydrolytic reaction, which is released from the non-reducing termini of substrates, remains bound 
to the enzyme’s active site. However, when a new substrate molecule approaches the enzyme, the 
glucose product diffuses away from the pocket and the incoming substrate enters the active site [4]. 
Both events are linked and a precise mechanism, how they proceed, is not known. We presume that the 
incoming substrate binds in the vicinity of the active site and could, by some delicate mechanism, 
instigate a product for new substrate interchange. We believe that this substrate/product interchange 
event represents an ideal model system to study, how products and incoming substrates interact in 
and/or near enzymes’ catalytic sites in general. 
Recently, we have reported the high level expression of recombinant HvExoI (designated as 
rHvExoI) from a codon-optimized HvExoI cDNA in protease-deficient Pichia pastoris under low 




temperature conditions [11]. We expect that rHvExoI could be used as a suitable enzyme model to 
study the roles of amino acid residues in catalysis and substrate specificity of this enzyme. To this end, 
we prepared variants of wild-type rHvExoI, altered (into Ala) in the key catalytic and substrate binding 
residues Glu220, Trp434 and Arg158/Glu161 by site-directed mutagenesis [12]. From the available 
structural data [2,7-10] we would expect that Glu220, Trp434 and Arg158 are surface exposed, while 
Glu161 is buried.  
In the current work, we describe the techniques and conditions for preparation of the wild-type and 
variant rHvExoI crystals that showed excellent diffraction parameters. These crystals were prepared by 
the macroseeding and cross-seeding techniques with microcrystals obtained from a native plant 
protein. Seeding techniques have previously been used successfully in bio-macromolecular 
crystallography [13]. The advantage of these techniques is that they use crystals that provide a 
preformed, regular surface, onto which new molecules may be added in a regular fashion, generally at 
a lower degree of supersaturation than is required for nucelation [13]. 
2. Results and Discussion 
2.1. Protein Expression and Purification 
Protein expression in P. pastoris at a temperature of 293 K, deglycosylation and purification yielded 
near-homogenous recombinant rHvExoI (Figure 1) with a molecular mass of 67,169 Da [11]. It is of 
note that rHvExoI contained at its NH2-terminus an 8x-His-tag and additional three Ala residues 
flanking the 8x-His-tag (AHHHHHHHHAA). The Ala residues resulted from the ligation-based 
cloning process, while the 8x-His-tag was added for protein purification purposes [11]. This 11-residue 
tag was not removed from the rHvExoI protein that was subjected to crystallisation trials. Expressed 
rHvExoI was catalytically competent with the catalytic efficiency value kcat.KM-1 = 14 mM-1.s-1 towards 
4-nitrophenyl β-D-glucoside. This second-order rate constant was similar to that reported for native 
fully N-glycosylated HvExoI [14] and a recombinant N-deglycosylated form [11]. Further, the 
biophysical properties of rHvExoI such as pH optimum and thermostability were also similar to those 
reported for native or recombinant HvExoI [11,14].  
2.2. Protein Crystallisation 
The concentrated rHvExoI was subjected to four types of crystallisation trials (Figures 2 and 3). We 
firstly set-up the microbatch under paraffin oil trials at 277 K and 287 K with the goal to screen 
approximately 130 independent conditions, including those that were previously found to be successful 
with a native plant enzyme [5]. These conditions (1.7 M ammonium sulfate, 75 mM HEPES-NaOH 
buffer, pH 7, containing 7.5 mM sodium acetate and 1.2% (w/v) PEG 400) previously produced 
crystals of native plant HvExoI that belonged to the primitive tetragonal space group P43212 and 
yielded high-resolution diffraction patterns [2,5,7]. Nevertheless, despite intensive effort, no 
diffraction-quality crystals grew, and after approximately 14 days only the formation of a highly 
intricate interlaced web of thin needles of approximately 40-60 µm in their longest dimensions was 
observed. Figure 2A and its inset show the appearance of these needles that grew from 1.6 M magnesium 
sulfate at pH 6.5 and 277 K.  




Our second approach to growing the diffraction quality crystals led us to set-up close to 400 trials at 
the Bio21 Collaborative Crystallisation Centre at 281 K and 293 K by a sitting-drop vapour-diffusion 
method. After approximately 21 days at 281 K, we could observe formation of short thin  
needle-shaped crystals that either remained dispersed throughout the droplets (Figure 2B) or formed 
well-organised round balls (Figure 2C). However, after about a month, in some of the droplets with 
needles (Figures 2B and 2C) truncated bi-pyramidal crystals formed, which reached dimensions of  
80  40  60 µm after about 97 days (Figure 2B). It was of note that these crystals were only observed 
at 281 K in droplets with 1.6 to 2.2 M ammonium sulfate, containing 10 mM malate-MES-Tris buffer, 
pH 5. These conditions were similar to the conditions that we found previously for native HvExoI [5], 
except that here the pH value of 5 was more acidic then that used previously (pH 7), and that the 
protein concentration was almost twice as high (12.5 mg.mL-1 versus 6.8 mg.ml-1). We expected that 
these truncated bi-pyramidal crystals could belong to the tetragonal P43212 space group found for the 
native protein crystals [5], although at this stage we were not able to collect their diffraction patterns. 
Notably, in an identical screen at a higher temperature of 293 K the bi-pyramidal crystals were not 
formed, so it seemed that the temperature was a critical factor for crystal formation of rHvExoI. 
Thirdly, we also attempted to grow crystals by self-nucleation at 277 K by hanging-drop vapour 
diffusion and using the conditions developed for native HvExoI [5]. However, we could not observe 
crystal formation within 180 days and rHvExoI mostly precipitated or the drops remained clear. 
Figure 1. SDS-PAGE profile of recombinant wild-type rHvExoI (lane 2) used for 
crystallisation by self-nucleation and macro- and cross-seeding using hanging-drop and 
sitting-drop vapour-diffusion methods. The rHvExoI protein (25 µg) was visualised with a 
Coomassie Brilliant Blue stain. Protein standards (5 µL of the Precision Plus Protein 
Standards’ stock) are indicated in lane 1. 
 
 
As no diffraction-quality crystals were obtained with the three crystallisation approaches described 
above, we turned our attention to seeding at 277 K using a hanging-drop vapour-diffusion method that 
was used successfully for preparation of large well-diffracting crystals of native HvExoI [7-10]. We 




first examined, if we could use microcrystals obtained from native HvExoI to seed the wild-type 
recombinant rHvExoI protein, despite the differences between the two proteins. These differences 
included the 11 additional residues of the affinity tag at the NH2-terminus, as described above. Further, 
the rHvExoI protein was N-deglycosylated by endoglycosidase H, such that only one N-linked  
N-acetyl-β-D-glucosaminyl residue [12] remained attached to each of the three N-glycosylation sites 
Asn221, Asn498 and Asn600 [2,11]. Approximately 48 h after rHvExoI was macroseeded with the 
native microcrystals of the sizes between 10  5  7.5 µm and 20  10  15 µm, the original native 
microcrystals started growing in size. The fully grown crystals of wild-type rHvExoI reached 
dimensions that varied between 100  50  75 µm (Figure 3B) and 500  250  375 µm after 5 to 7 
days and these crystals had a similar bi-pyramidal morphology as the native microcrystals (Figures 
3A). Having succeeded in growing wild-type crystals, using native microcrystal seeds, we prepared 
large recombinant crystals of three rHvExoI variants, specifically Glu220Ala (Figure 3C), Trp434Ala 
and of the double mutant Arg158Ala/Glu161Ala, also using native seed crystals. The newly grown 
variant crystals reached sizes of 100  50  75 µm (Figure 3C) to 500  250  375 µm and showed a 
similar bi-pyramidal morphology as the native microcrystals. The variant crystals grew slightly slower 
and reached their maximum dimensions after 10-14 days. 
Figure 2. Crystals of recombinant wild-type rHvExoI grown by self-nucleation. Various 
forms of crystals grown for 14 (A) and 97 (B-C) days using a microbatch-under-paraffin-
oil technique from 1.6 M magnesium sulfate, pH 6.5 at 277 K (A) or obtained using  
sitting-drop vapour-diffusion from 1.8 (B) or 2.2 M (C) ammonium sulfate, both at pH 5 
and 281 K. The crystals in (A) formed thin needles of approximately 40-50 µm in their 
longest dimensions (inset), while in B and C short thin needles are shown that appeared 
within 14 days and after another 30 days the truncated bi-pyramidal crystals grew that 
reached dimensions of 80  40  60 µm after 97 days. 
2.3. X-ray Diffraction 
Single wild-type and variant rHvExoI crystals were cryo-protected and subjected to diffraction at 
the MX1 beamline of the Australian Synchrotron. All of the X-ray diffraction data sets were virtually 
complete beyond 1.57-1.95 Å (Figure 4; Table 1). The HKL2000 indexing and systematic absences 
calculated that the space groups of the wild-type and variant rHvExoI crystals were consistent with a 




primitive tetragonal space group P43212 (Figure 4 and Table 1), and as expected, these space group 
characteristics were similar to their native counterparts [2,7]. In line with these observations was our 
previous finding that the native HvExoI microcrystals of the sizes 20  10  15 µm diffracted beyond 
2.80 Å on an in-house rotating anode X-ray source and belonged to a primitive tetragonal space group 
P43212 [15]. Thus, our data are in agreement with other reports, where the space group characteristics 
of macroseeds and fully grown crystals were identical [16-18], or that as a bonus, the resolution of the 
newly grown crystals has improved [18]. On the contrary, other authors have reported that during 
seeding trials mutant crystals often crystallized in different space groups than their macroseeds [19].  
Figure 3. Microcrystals (10  5  7.5 µm to 20  10  15 µm) of native HvExoI (A) used 
to grow the recombinant wild-type (B) and variant Glu220Ala (C) rHvExoI crystals that 
grew to their full-sizes within 5-14 days. The crystals obtained by seeding in hanging-
drops by vapour-diffusion grew to dimensions of up to 500  250  375 µm at 277 K. 
 
The best diffraction data, to 1.57 Å were collected from the wild-type crystals, followed by the 
Arg158Ala/Glu161Ala, Glu220Ala and Trp434Ala variants that diffracted to 1.65 Å, 1.90 Å and  
1.95 Å, respectively (Figure 4, Table 1). The lattice dimensions of wild-type and variant crystals varied 
between a = b = 99.2-100.8 Å and c = 183.2-183.6 Å, and there appeared to be one molecule in the 
asymmetric units, according to the Matthews coefficient calculation [20]. The Matthews coefficients of 
recombinant crystals were between 3.4-3.5 Å3.Da-1 with solvent contents of 63.4% to 64.5%. The 
Rmerge values of 5.6% to 10.1% were obtained with <I/σ/(I)> of 37.0 to 71.2, whereas the multiplicity 
of the individual datasets was well above 20 and varied between 26 to 29 (Table 1). It was of note that 
the completeness for the highest resolution shells of the wild-type and Glu220Ala datasets was lower, 
despite the high multiplicity and crystal symmetry, because the data were integrated into the corners of 
the detector. Also, the mean <I/σ/(I)> values for these datasets indicated that they actually diffracted to 
higher resolution than that stated in Table 2. It was not surprising that the most favourable diffraction 
statistics was obtained with the wild-type crystals that were seeded with the wild-type native 
macroseeds (Figure 4 and Table 1).  
  




Table 1. Data collection statistics from the wild-type and variant rHvExoI crystals, 
calculated by the HKL2000 suite of programs. 
 Wild-type Glu220Ala Trp434Ala Arg158Ala/Glu161Ala 
Unique reflections 119968 74171  64460 107601 
Resolution a (Å) 1.57 (1.6-1.57) 1.90 (1.94-1.90) 1.95 (1.98-1.95) 1.65 (1.68-1.65) 
Mean multiplicity a,b 29 (26) 27 (16) 27 (16) 26 (12) 
Completeness a,b (%) 99 (86) 99 (88) 100 (100) 99.8 (98) 
Mean <I/σ/(I)> a 71.2 (5.6) 54.8 (4.3) 37.0 (2.2) 58.7 (2.3) 
Rmerge a-c (%) 6.7 (47) 8.9 (64) 10.1 (87) 5.6 (82) 
a = b (Å) d 99.2 100.2 100.1 100.8 
c (Å) d 183.5 183.2 183.6 183.2 
a Numbers in parenthesis represent the values in the highest resolution shell. 
b The numbers were rounded to no decimal place. 
c Rmerge = 100[∑(Ii-<I>)2/∑Ii2] is summed over all independent reflections. 
d The numbers were rounded to the 1st decimal place. 
Figure 4. X-ray diffraction patterns of the recombinant wild-type (A), and variant 
Glu220Ala (B), Trp434Ala (C) and Arg158Ala/Glu161Ala (D) rHvExoI crystals. The left 
top insets show diffraction intensities to 1.59-1.89 Å (A), 1.99-2.41 Å (B and C) and  
1.83-2.20 Å (D). 




3. Experimental Section 
3.1. Expression and Purification of Wild-Type and Variant Forms of rHvExoI 
Wild-type (GenBank accession No. GU441535) and variant codon-optimized cDNAs, encoding a 
mature barley β-D-glucan exohydrolase I (HvExoI) inserted in pPICZαBNH8 expression vectors, were 
expressed in P. pastoris, strain SMD1168H and purified by ion exchange, immobilized metal affinity 
chromatography (IMAC), N-deglycosylation by endoglycosidase H and a second round of IMAC, as 
described previously [11]. The variant forms included Glu220Ala, Trp434Ala and a double mutant 
Arg158Ala/Glu161Ala, for which the constructions of the cDNA fusions will be described elsewhere 
[12]. At the final purification step before crystallisation, the N-deglycosylated rHvExoI wild-type and 
variant enzymes were eluted from a BioGel-P100 size-exclusion column with 50 mM sodium acetate 
buffer, pH 5.25 containing 200 mM NaCl and 1 mM dithiothreitol at a liner flow rate of 0.5 cm.h-1. 
The protein purities of the rHvExoI fractions were analyzed by SDS-PAGE, using 12.5% w/v 
polyacrylamide and bis-polyacrylamide gels and standard techniques [6]. The protein concentration 
was estimated with a Bio-Rad protein assay kit (Bio-Rad Laboratories, Gladesville, New South Wales, 
Australia) using bovine serum albumin (Sigma Chemical Company, St. Louis, MO, USA) as a 
standard. The protein standards ‘Precision Plus Protein Standards’ used for SDS-PAGE were from 
Bio-Rad Laboratories. 
3.2. Enzyme Assays 
The activities of pooled and concentrated (using 10 kDa cut-off centrifugal filter units (Millipore, 
Bedford, MA, USA) wild-type and variant enzymes were assayed against 4-nitrophenyl  
β-D-glucopyranoside (Sigma) in 50 mM sodium acetate buffer, pH 5.25.  
3.3. Crystallisation of Wild-Type and Variant Forms of rHvExoI  
Near-homogenous N-deglycosylated wild-type and variant rHvExoI proteins were concentrated to 
12.5 mg.mL-1 in 20 mM sodium acetate pH 5.25 and filtered through a 0.22 µm filter (Millipore). 
Screening of crystallisation conditions was performed by four experimental approaches. Firstly, initial 
crystallisation conditions were screened using a microbatch under paraffin oil technique. Here,  
1 µL of precipitant solutions and 1 µL of the solution containing 12.5 mg.mL-1 of rHvExoI were added 
into 10 µL of 100% Paraffin oil (Hampton Research, Aliso Viejo, CA, USA) that was previously 
dispensed in microbatch 72 well Greiner (Terasaki style) plates (Hampton Research). The formulations 
of Crystal Screen 2, Crystal Screen Lite and Grid Screen Ammonium Sulfate (Hampton Research) 
were used as precipitants and the crystals grew at 277 K or 287 K in a vibration-free crystallographic 
cabinet (Molecular Dimensions, Suffolk, UK). Secondly, crystallisation trials were set-up robotically 
(Phoenix Nano-Dispenser, Art Robbins Instruments, Sunnyvale, CA, USA) in sitting drops, in which 
300 nL droplets of rHvExoI were mixed with the same volumes of precipitants and crystal growth 
proceeded at 281 K and 293 K at the Bio21 Collaborative Crystallisation Centre (CSIRO, Parkville, 
Australia) [21]. The precipitants from the PSS_1_Com5 and PS gradient-mid range formulation 
screens were used, whereas both screens were prepared in-house at the Bio21 Centre 




(http://www.csiro.au/c3/Facility/c3_centre_robotic_crystal.htm), following the recommendation from 
Emerald BioSystems (Bainbridge Island, WA, USA) for the first screen and those reported by 
Newman [22] for the second screen. The PSS_1_Com5 screen uses the inorganic precipitants such as 
sulfates, chlorides, citrates and phosphates, but also 2-methyl-2,4-pentanediol, glycerol and 
polyethyleneglycols (PEGs) in the pH ranges of 5-8.7. On the other hand, the PS gradient-mid range 
formulation relies on ammonium sulfate and sodium malonate as precipitants in a 10 mM malate-
MES-Tris buffer system in the pH ranges of 4.5-9 [22]. Thirdly, attempts were made to grow crystals 
under the conditions developed for native HvExoI at 277 K using a hanging-drop vapour diffusion 
method [5]. Lastly, and most importantly, the rHvExoI crystals were grown in hanging drops at 277 K 
that were seeded with the native HvExoI microcrystals prepared as described previously [5]. The sizes 
of the microcrystals for the latter conditions varied between 10  5  7.5 µm and 20  10  15 µm. The 
hanging drops were prepared at 277 K as follows. The volume of 4 to 6 µL of rHvExoI at  
12.5 mg.mL-1 was added to 4 µL of the precipitant solution A (100 mM HEPES-NaOH buffer pH 7, 
2.4% (w/v) PEG 400, 1.6 M ammonium sulfate) on 22-mm siliconized circular glass cover slips 
(Hampton Research). A few microcrystals of native HvExoI were transferred into the hanging drop 
with a cat whisker. Here, the whisker gently touched the surface of a macroseed stock of native 
HvExoI and subsequently the whisker was swiftly immersed into a new rHvExoI drop. The cover slips 
with the seeded hanging drops were placed over 1 mL of reservoir solutions (1.7 M ammonium sulfate 
in 50 mM HEPES-NaOH buffer, pH 7) contained in the 24 well Linbro plates (Hampton Research), 
and the wells were sealed with vacuum grease (Dow Corning Corporation, Midland, MI, USA). 
Crystals from the seeded drops appeared within 5-14 days and were suitable for X-ray data collection. 
The crystals were photographed through a Leica Laser Microdissection microscope (Leica, North 
Ryde, Australia) equipped with fluorescence and differential interference contrast. 
3.4. X-ray Data Collection and Processing  
Single enzyme crystals with the longest dimensions of 100 to 500 μm were cryo-protected in  
20% (v/v) glycerol concentration in solution A (as specified above in Section 3.3.) [10] and flash 
cooled in the cold N2 stream at the beamline MX1 of the Australian Synchrotron. X-ray diffraction 
data sets were collected at 0.5° oscillations (1 sec exposures) through 360° on the ADSC Quantum 
210r Detector [23]. The data were processed with the HKL2000 suite of programs [24]. 
4. Conclusions 
In summary, excellent X-ray diffraction data were obtained from the recombinant wild-type and 
variant rHvExoI crystals grown by seeding from a native plant source protein in hanging-drops by 
vapour-diffusion. The recombinant crystals grew relatively fast and within 5-14 days reached 
dimensions of up to 500  250  375 µm. The fully grown recombinant crystals retained the space 
group characteristics of their native macroseeds and diffracted beyond 1.57 Å to 1.95 Å. As reported 
for other proteins, this technique could be valuable, where a limited amount of variant proteins is 
available precluding crystallisation trials, or where variant protein forms could not be crystallized. We 
project that cross-seeding using native protein as a source of microcrystals could be successfully used 
for generation of large recombinant wild-type and variant crystals that could potentially yield high 




resolution diffraction patterns. Lastly, the diffraction data collected from the wild-type and variant 
rHvExoI crystals reported here could be used successfully for structure solution. The structural data are 
currently being prepared for publication [12].  
Acknowledgements 
The authors acknowledge the MX1 beamline at the Australian Synchrotron (Victoria, Australia) and 
Janet Newman from the Bio21 Collaborative Crystallisation Centre (Melbourne, Australia). We are 
also grateful to Gwenda Mayo (Australian Centre for Plant Functional Genomics) for taking 
photographs of crystals. This work was supported by grants from the Australian Research Council to 
M.H., the Thailand Research Fund (TRF) to J.R.K.C. and a TRF Royal Golden Jubilee PhD 
Fellowship to S.L. The constructive help of both anonymous referees is also acknowledged. 
References 
1. Cantarel, B.L.; Coutinho, P.M.; Rancurel, C.; Bernard, T.; Lombard, V.; Henrissat, B. The 
Carbohydrate-Active EnZymes database (CAZy): An expert resource for glycogenomics. Nucleic 
Acids Res. 2008, 37, D233-D238. 
2. Varghese, J.N.; Hrmova, M.; Fincher, G.B. Three-dimensional structure of a barley β-D-glucan 
exohydrolase; a family 3 glycosyl hydrolase. Struct. Fold. Des. 1999, 7, 179-190. 
3. Pozzo, T.; Pasten, J.L.; Karlsson, E.N.; Logan, D.T. Structural and functional analyses of beta-
glucosidase 3B from Thermotoga neapolitana: A thermostable three-domain representative of 
glycoside hydrolase 3. J. Mol. Biol. 2010, 397, 724-739. 
4. Hrmova, M.; Fincher, G.B. Dissecting the catalytic mechanism of a plant β-D-glucan 
glucohydrolase through structural biology using inhibitors and substrate analogues. Carbohydr. 
Res. 2007, 305, 209-221. 
5. Hrmova, M.; Varghese, J.N.; Høj, P.B.; Fincher, G.B. Crystallization and preliminary X-ray 
analysis of β-glucan exohydrolase isoenzyme ExoI from barley (Hordeum vulgare). Acta Cryst. 
1998, D54, 6887-689. 
6. Hrmova, M.; Harvey, A.J.; Wang, J.; Shirley; N.J.; Jones; G.P.; Høj; P.B.; Fincher, G.B. Barley  
β-D-glucan exohydrolases with β-D-glucosidase activity. Purification and determination of primary 
structure from a cDNA clone. J. Biol. Chem. 1996, 271, 5277-5286. 
7. Hrmova, M.; Varghese, J.N.; DeGori, R.; Smith, B.J.; Driguez, H.; Fincher, G.B. Catalytic 
mechanisms and reaction intermediates along the hydrolytic pathway of plant β-D-glucan 
glucohydrolase. Struct. Fold. Des. 2001, 9, 1005-1016. 
8. Hrmova, M.; DeGori, R.; Smith, B.J.; Driguez, H.; Varghese, J.N.; Fincher, G.B. Structural basis 
for a broad specificity in higher plant β-D-glucan glucohydrolases. Plant Cell 2002, 14,  
1033-1052. 
9. Hrmova, M.; De Gori, R.; Smith, B.J.; Vasella, A.; Varghese, J.N.; Fincher, G.B. Three-
dimensional structure of the barley β-D-glucan glucohydrolase in complex with a transition state 
mimic. J. Biol. Chem. 2004, 279, 4970-4980. 




10. Hrmova, M.; Streltsov, V.A.; Smith, B.J.; Vasella, A.; Varghese, J.N.; Fincher, G.B. Structural 
rationale for low nanomolar binding of transition state mimics to a family GH3 β-D-glucan 
glucohydrolase from barley. Biochemistry 2005, 44, 16529-16539. 
11. Luang, S.; Hrmova, M.; Ketudat Cairns, J.R. High-level expression of barley β-D-glucan 
exohydrolase HvExo I from a codon-optimized cDNA in Pichia pastoris. Prot. Expr. Purif. 2010, 
73, 90-98. 
12. Luang, S.; Streltsov, V.A.; Ketudat Cairns, J.R.; Hrmova, M. Characterization of variant forms of 
β-D-glucan glucohydrolase from barley (Hordeum vulgare L). Biochem. J. 2010, to be submitted. 
13. Stura, E.; Wilson, I.A. Analytical and production seeding techniques. Methods 2000, 1, 38-49. 
14. Hrmova, M.; Fincher, G.B. Barley β-D-glucan exohydrolases. Substrate specificity and kinetic 
properties. Carbohydr. Res. 1998, 305, 209-221. 
15. Varghese, J.N.; van Donkelaar, A.; Balaic, D.X.; Barnea, Z. CSIRO-Commonwealth Scientific 
Research Organization. Personal communication, Melbourne, Victoria, 2001. 
16. Radaev, S.; Agniswamy, J.; Sun, P.D. A case of structure determination using pseudosymmetry. 
Acta Cryst. 2009, D65, 1334-1340. 
17. Stec, B.; Holtz, K.M.; Wojciechowski, C.L.; Kantrowitz, E.R. Structure of the wild-type TEM-1 
β-lactamase at 1.55 Å and the mutant enzyme Ser70Ala at 2.1 Å suggest the mode of noncovalent 
catalysis for the mutant enzyme. Acta Cryst. 2005, D61, 1072-1079. 
18. Heaslet, H.; Rosenfeld, R.; Giffin, M.; Lin, Y.-C.; Tam, K.; Torbett, B.E.; Elder, J.H.; McRee, 
D.E.; Stout, C.D. Conformational flexibility in the flap domains of ligand free HIV protease. Acta 
Cryst. 2007, D63, 866-875. 
19. Mizutani, H.; Saraboji, K.; Malathy Sony, S.M.; Ponnuswamy, M.N.; Kumarevel, T.; Krishna 
Swamy, B.S.; Simanshu, D.K.; Murthy, M.R.; Kunishima, N. Systematic study on crystal-contact 
engineering of diphthine synthase: Influence of mutations at crystal-packing regions on X-ray 
diffraction quality. Acta Cryst. 2008, D64, 1020-1033. 
20. Matthews, B.W. Solvent content of protein crystals. J. Mol. Biol. 1968, 33, 491–497. 
21. Newman, J.; Pham, T.M.; Peat, T.S. Phoenito experiments: combining the strengths of 
commercial crystallization automation. Acta Cryst. 2008, F64, 991-996. 
22. Newman, J. Optimization of buffer solutions for protein crystallization. Acta Cryst. 2004, D60, 
610-612. 
23. McPhillips, T.M.; McPhillips, S.E.; Chiu, H.J.; Cohen, A.E.; Deacon, A.M.; Ellis, P.J.; Garman, 
E.; Gonzalez,; Sauter, N.K; Phizackerley, R.P.; Soltis, S.M.; Kuhn, P. Blu-ice and the distributed 
control system: Software for data acquisition and instrument control at macromolecular 
crystallography beamlines. J. Synchrotron Radiat. 2002, 9, 401-406. 
24. Otwinowski, Z.; Minor, W. Processing of X-ray diffraction data collected in oscillation mode. 
Methods Enzymol. 1997, 276, 307-326. 
© 2010 by the authors; licensee MDPI, Basel, Switzerland. This article is an Open Access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 
